Christopher M. Haqq

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.3K citations · Full text

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Karim Fizazi, Howard I. Scher, Arturo Molina et al. · The Lancet Oncology · 2012 · 1.4K citations

Urology, Placebo-controlled Phase 3, Abiraterone Acetate +6

The gene expression signatures of melanoma progression

Christopher M. Haqq, Mehdi Nosrati, Daniel Sudilovsky et al. · Proceedings of the National Academy of Sciences · 2005 · 431 citations · Full text

Tumor Biology, Melanoma Metastases, Gene Expression Signatures +15

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Daniel C. Danila, Michael J. Morris, Johann S. de Bono et al. · Journal of Clinical Oncology · 2010 · 409 citations · Full text

Cell- and gene-specific regulation of primary target genes by the androgen receptor

Eric C. Bolton, Alex Yick‐Lun So, Christina Chaivorapol et al. · Genes & Development · 2007 · 343 citations · Full text

Androgen Receptor, Genetics, Primary Target Genes +19